A community for people who want to remain as healthy as possible as we age.

Expensive new Hep C drugs may be cost-effective even for early disease

(Reuters Health) Treating hepatitis C with expensive new medicines at the earliest signs of liver damage improves patients' health and is also cost-effective, a new computer simulation suggests.
"Going into this, I expected to find it did make sense to wait until there was a limited amount of liver disease, but what we found to our surprise is that it makes sense to start treatment at the earliest change in the liver," said senior author Dr. James Kahn, of the University of California, San Francisco…
While other studies found the new drugs to be cost effective, the new study looked at whether that's true at each stage of liver damage. Some insurers won't let patients take the drugs until their liver disease is advanced.
[Click the title, above, to post a comment.]

0 comments:

Post a Comment

Please do not give advice. We can best help each other by telling what works for us, not what we think someone else should do.